Gait Adaptability Training, Using Augmented Reality, for Individuals in the Chronic Phase After Stroke

Last updated: April 11, 2023
Sponsor: Sint Maartenskliniek
Overall Status: Active - Recruiting

Phase

N/A

Condition

Stroke

Cerebral Ischemia

Treatment

N/A

Clinical Study ID

NCT05827380
NL80178.091.21 / 0996
  • Ages > 18
  • All Genders

Study Summary

Background: The majority of stroke survivors regain walking ability, however the ability to adapt their gait to meet environmental demands remains impaired. This impaired gait adaptability has a profound impact on activities of daily living and quality of life. Treatment targeting these gait deficiencies is, therefore, critical for allowing safe and independent community ambulation in people with stroke. Rehabilitation programs targeting gait adaptability have gained interest in clinical practice. Besides, the use of augmented and virtual reality in rehabilitation programs becomes more common. Concerning gait adaptability, training programs are developed using the Cmill, an instrumented treadmill with augmented reality. Even though the efficacy of these interventions is limited to small, pilot trials, results are promising. Based on these results we hypothesize that a gait training program using the Cmill will improve gait adaptability and daily-life gait performance in people in the chronic phase after stroke.

Objective: The primary objective of this study is to evaluate the efficacy of a gait training program using an instrumented treadmill with virtual and augmented reality for improving gait adaptability in people in the chronic phase after stroke. A second objective is to identify patient characteristics that predict a more favorable response to training.

Study design: Randomized, waiting-list controlled trial to evaluate gait adaptability training

Study population: 84 stroke patients in the chronic phase after stroke

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • > 6 months after first unilateral supratentorial stroke (chronic phase)
  • Able to walk at least 10 minutes independently

Exclusion

Exclusion Criteria:

  • Any other neurological or musculoskeletal disease affecting gait or balance (e.g.Parkinson's disease, knee osteoarthritis)
  • Contractures or spasticity requiring other treatment (e.g. botulinum toxin treatment)within the duration of the training period.
  • Has received multiple training sessions on C-Mill or GRAIL in the past 12 months
  • Severe cognitive or visuo-spatial impairments limiting comprehension of instructionsor correct perception of the environments

Study Design

Total Participants: 84
Study Start date:
September 22, 2022
Estimated Completion Date:
December 31, 2024

Connect with a study center

  • Sint Maartenskliniek

    Ubbergen, 6574NA
    Netherlands

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.